News & Articles

Clinicians can now get results at the patient's bedside, making the test accessible at urgent care clinics and other healthcare settings

FreeStyle Libre system can help reduce acute diabetes-related events, such as severe hypoglycaemia and diabetic ketoacidosis, leading to a 67% drop in hospitalizations

The three companies will work to accelerate development of automated insulin delivery system for people living with diabetes

The technology provides a 360-degree view of the heart, regardless of catheter orientation, for cardiac mapping without compromise

NeuroSphere Virtual Clinic utilizes advancements in digital technology to optimize care for patients with chronic pain or movement disorders

Amulet device is the first minimally invasive option approved for left atrial appendage occlusion that does not require blood-thinning medication

The Amulet is the first and only minimally invasive treatment option to offer immediate closure of the left atrial appendage, so blood-thinning medication isn't needed following implantation

The new intuitive interface provides step-by-step guidance to enhance ease of use

The new XIENCE Skypoint stent received FDA approval in the U.S. and CE Mark approval in Europe

Panbio COVID-19 Antigen Self-Test is approved for sale directly to consumers, enabling fast, convenient coronavirus testing

The Panbio self-test features a minimally invasive nasal swab and delivers results in as early as 15 minutes with no instrumentation, using proven Abbott lateral flow technology

The first-of-its-kind steerable delivery system is designed to seal the left atrial appendage in people who are at increased risk of stroke due to atrial fibrillation

Access to mechanical circulatory support devices is critical for advanced heart failure patients and can improve survival, clinical outcomes and quality of life

First rapid antigen test with performance data on children

The Ultreon 1.0 Software helps physicians automatically detect and quantify blood vessel characteristics, giving them better insights for optimal patient treatment

The BinaxNOW Self-Test will be sold in 2-count packs for an MSRP of $23.99, making it an affordable over-the-counter COVID-19 rapid test available in the U.S.

The next-generation therapy offers enhanced leaflet grasping feature and new clip sizes to fit each patient's complex tricuspid valve anatomy

Abbott will rapidly develop tests that can be used to help identify, isolate, and contain outbreaks when potential new virus threats are identified

Newly FDA-approved system allows a patient to both communicate with a physician and remotely receive stimulation settings in real time regardless of location

The test helps save on much-needed testing supplies since it allows for testing for all four viruses with one swab

Discovery is a result of Abbott's continued virus hunting efforts, which also uncovered a new strain of HIV in 2019